The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

As of February 17, 2025, 1,028 unique patient prescriptions for Attruby™ have been written by 516 unique prescribers since FDA approval- ...

Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...

Innovative Bispecific Antibody Therapies in Cancer Treatment Emerge as Patent Filings SurgeDublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody & Cancer Patent Landscape Analysis" report ...

AI companies in the US operate within a complex regulatory landscape shaped by multiple agencies and industry-specific laws.

A judge issued a temporary restraining order against the Trump administration, ordering it to restore numerous webpages that ...

Russia’s unjustified and unprovoked invasion of Ukraine and the weaponisation of energy have made diversification of energy supplies a necessity for EU countries. Diversification is a lengthy and ...

The European Commission has adopted legislation requiring EU countries to do Whole Genome Sequencing (WGS) during foodborne ...

In response to this growing health crisis, nine EU-backed projects have joined forces in an unprecedented collaborative effort, leading to the formation of OBEClust: the European Cluster of ...

Europeans' desire to store online knows no bounds and is creating new problems. This is now prompting the EU Commission, which wants to put a stop to the flood of parcels with a new package of ...

SILVER SPRING, Md., Feb. 5, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose ...